You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
沃華醫藥(002107.SZ):聘任原公司副總裁曾英姿擔任公司總裁
格隆匯 12-06 15:52

格隆匯12月6日丨沃華醫藥(002107.SZ)公佈,公司於近日收到公司總裁李盛廷提出的書面辭職報告,李盛廷因工作調整申請辭去公司總裁的職務。根據相關法律、法規及《公司章程》的規定,其提交的辭職報告自送達董事會之日起生效。

李盛廷自2001年調任公司以來,曾長期擔任工廠廠長、營銷總監等職務,兼通生產管理和市場營銷。李盛廷參與了公司改制、上市及上市後發展的全過程,積累了豐富的醫藥上市公司經營管理的經驗和資源。自2017年擔任公司總裁以來,恪盡職守、勤勉盡責,帶領公司員工全面準確地執行董事會各項決策,使公司在政策鉅變、競爭激烈的行業環境下保持穩健增長,為公司步入長期、健康、可持續發展軌道發揮了重要作用。董事會對李盛廷先生任職期間為公司做出的貢獻表示衷心感謝。

經董事長提名,第六屆董事會提名委員會資格審查通過,董事會同意聘任原公司副總裁曾英姿擔任公司總裁,任期同本屆董事會。

曾英姿長期負責公司產品研發、質量管理等工作,擁有豐富的中藥研發、品種引進和質量控制經驗。作為“鳶都學者”、中國中醫藥協會副會長,多次主持或參與國家和山東省重點科研項目,積累了豐富的中藥行業研發資源。相信曾英姿在繼任總裁後,能夠在豐富公司獨家產品線、提升公司產品質量及標準等方面做出更大的貢獻,推動公司更好更快地發展。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account